| BSE: 532331 | Sector: Health care |
| NSE: AJANTPHARM | ISIN Code: INE031B01049 |
| BSE 00:00 | 19 Feb | 1314.20 |
21.20 (1.64%) |
OPEN
1313.00 |
HIGH
1346.65 |
LOW
1303.15 |
| NSE 00:00 | 19 Feb | 1314.10 |
15.35 (1.18%) |
OPEN
1317.55 |
HIGH
1355.35 |
LOW
1302.20 |
| OPEN | 1313.00 |
| PREVIOUS CLOSE | 1293.00 |
| VOLUME | 9615 |
| 52-Week high | 1483.40 |
| 52-Week low | 840.00 |
| P/E | 29.03 |
| Mkt Cap.(Rs cr) | 11,466 |
| Buy Price | 1305.05 |
| Buy Qty | 25.00 |
| Sell Price | 1306.55 |
| Sell Qty | 20.00 |
Ajanta Pharma is a specialty pharmaceutical company engaged in development manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The company's business includes Branded Generics in emerging markets of Asia and Africa Generics in the developed markets of ...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Mannalal B Agrawal | ||||||
| Vice Chairman : | Madhusudan B Agrawal | ||||||
| Managing Director : | Yogesh Agrawal | ||||||
| Independent Director : | Chandrakanth M Khetan | ||||||
| Company Secretary : | Gaurang Shah | ||||||
| Joint Managing Director : | Rajesh M Agrawal | ||||||
| Independent Director : | K H Viswanathan | ||||||
| Independent Director : | Prabhakar Dalal | ||||||
| Independent Director : | Anjana Grewal | ||||||
| AUDITOR : | B S R & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Ajanta House, Charkop Kandivli (W),Mumbai,Maharashtra-400067 | |||||||
| Ph : 91-22-66061000/1204/1203 | |||||||
| WEBSITE : http://www.ajantapharma.com | |||||||
| E-mail : info@ajantapharma.com | |||||||
